What a peptide is
A peptide is a chain of amino acids, the building blocks of proteins. Many naturally occurring signals in the body are peptides. The category describes a chemical structure, not a medical purpose. Insulin, semaglutide, tirzepatide and investigational substances can all be discussed as peptides, but their evidence, indications, quality controls and legal status differ greatly.
Authorised medicines versus experiments
Wegovy and Mounjaro have official European product information explaining indications, dosing, warnings and adverse effects. A clinician must assess whether a medicine is suitable for a particular patient. Online discussion of retatrutide, CagriSema, BPC-157, CJC-1295 or ipamorelin should be read in the context of their specific stage of research. A promising laboratory result or early trial is not the same as a marketing authorisation. Check each product by name and date, because development status can change.
Why the injury and muscle claims need care
People search for peptides to heal tendons, build muscle or recover faster. These claims often combine animal findings, anecdotes and advertisements. For BPC-157, a registered trial in acute hamstring injury is testing whether it helps people; its existence does not establish the outcome. Someone with a sports injury needs a diagnosis, a rehabilitation plan and, where necessary, imaging or specialist assessment. For muscle growth, consistent resistance training and adequate nutrition have a clearer evidence base than buying a vial of unknown identity.
What an online seller cannot tell you
A label saying “laboratory grade” does not establish the contents, dose, sterility or suitability for human use. A foreign website or a social media testimonial is not a medicines regulator. Check official registers and speak to a clinician or pharmacist. INFARMED provides information about authorised medicines and licensed pharmacy services in Portugal. Do not self-inject an investigational compound bought online.
What to watch next
Follow published clinical trial results, regulatory decisions and updates to official product information, rather than a projected launch date. Good questions include: Was the result measured in people? Was there a comparison group? What was the absolute benefit and what adverse effects occurred? Was the studied product the same formulation being sold? Costa will update its guides as reliable evidence and authorisations change.